How AlphaFold is Driving India’s Life Sciences Industry
The southern Indian state of Telangana is attracting significant investments in the life sciences sector, with global firms expanding their presence in the region. Recent announcements include investments from companies in France, Indonesia, and the US, with plans to establish new facilities and create jobs in the sector.
Telangana is emerging as a hub for life sciences in India, with Hyderabad at its center. The state accounts for a significant portion of India's pharmaceutical production and exports. Recent investment announcements include a 42,000 sq. ft. facility by Opella Healthcare, a BSL-3 vaccine manufacturing facility by Vaksindo Animal Health, and a healthcare and life sciences analytics hub by Tredence Inc. The state government has also announced plans to expand Genome Valley, a biotech and pharmaceutical hub, with state-of-the-art infrastructure facilities. Telangana aims to attract $25 billion in investments and generate 500,000 jobs in the sector by 2030.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.